Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-... von Hurvitz, Sara A, Dr, Andre, Fabrice, Prof, Jiang, Zefei, Prof, Shao, Zhimin, Prof, Mano, Max S, MD, Neciosup, Silvia P, MD, Tseng, Ling-Min, MD, Zhang, Qingyuan, Prof, Shen, Kunwei, Prof, Liu, Donggeng, Prof, Dreosti, Lydia M, Prof, Burris, Howard A, MD, Toi, Masakazu, Prof, Buyse, Marc E, Prof, Cabaribere, David, MSc, Lindsay, Mary-Ann, PhD, Rao, Shantha, PhD, Pacaud, Lida Bubuteishvili, MD, Taran, Tetiana, MD, Slamon, Dennis, Prof

Volltext

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pa... von de Azambuja, Evandro, Dr, Holmes, Andrew P, PhD, Piccart-Gebhart, Martine, MD, Holmes, Eileen, PhD, Di Cosimo, Serena, MD, Swaby, Ramona F, MD, Untch, Michael, MD, Jackisch, Christian, MD, Lang, Istvan, MD, Smith, Ian, MD, Boyle, Frances, MBBS, Xu, Binghe, MD, Barrios, Carlos H, MD, Perez, Edith A, MD, Azim, Hatem A, MD, Kim, Sung-Bae, MD, Kuemmel, Sherko, MD, Huang, Chiun-Sheng, MD, Vuylsteke, Peter, MD, Hsieh, Ruey-Kuen, MD, Gorbunova, Vera, MD, Eniu, Alexandru, MD, Dreosti, Lydia, MD, Tavartkiladze, Natalia, MD, Gelber, Richard D, PhD, Eidtmann, Holger, MD, Baselga, José, MD

Volltext

Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer von Redondo, Andres, Colombo, Nicoletta, McCormack, Mary, Dreosti, Lydia, Nogueira-Rodrigues, Angelica, Scambia, Giovanni, Lorusso, Domenica, Joly, Florence, Schenker, Michael, Ruff, Paul, Estevez-Diz, Maria, Irahara, Natsumi, Donica, Margarita, Gonzalez-Martín, Antonio

Volltext

Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International Multicenter Retros... von Brittain, David, Akhtar, Saad, Rodrigues, Sylvia, Patel, Moosa, Moodley, Dhaya, Singh, Jaimendra Prithipal, Dreosti, Lydia M, Mohamed, Zainab, Al-Mansour, Mubarak, Alzahrani, Mohsen, Rauf, M Shahzad, Maghfoor, Irfan, Kalayoğlu Beşışık, Sevgi, Boğa, Can, Saydam, Güray, Huang, Zhongwen, Pinchevsky, Yacob, Ferhanoğlu, Burhan

Volltext

Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial von AZIM, Hatem A, AGBOR-TARH, Dominique, AKTAS, Bahriye, HUANG, Chiun-Sheng, VUYLSTEKE, Peter, RUEY KUEN HSIEH, DREOSTI, Lydia, EIDTMANN, Holger, PICCART, Martine, DE AZAMBUJA, Evandro, BRADBURY, Ian, PHUONG INH, BASELGA, Jose, DI COSIMO, Serena, GREGER, James G, SMITH, Ian, JACKISCH, Christian, KIM, Sung-Bae

Volltext

Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvement von Zekri, Jamal, Dreosti, Lydia M, Ghosn, Marwan, Hamada, Emad, Jaloudi, Mohamed, Khorshid, Ola, Larbaoui, Blaha

Volltext

Geoffrey Falkson, 9 August 1932 - 10 January 2019 von Dreosti, Lydia Mary

Volltext

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, con... von Kowalski, Dariusz M, Cho, Byoung Chul, Lubiniecki, Gregory M, Kush, Debra, Lopes, Gilberto, Adamchuk, Grigory, Ahn, Myung-Ju, Altundag, Ozden, Aoe, Keisuke, Ativitavas, Touch, Beato, Carlos, Bergstrom, Per, Betticher, Daniel, Buddu, Sayeuri, Castro, Hugo, Cay Senler, Filiz, Cerny, Carlos Alexandre Sydow, Chan, Gee-Chen, Chang, Jianhua, Cheng, Susanna, Cherciu, Nelly, Cho, Byoung Chul, Cicenas, Saulius, Cohen, Graham, Costa, Marcos Andre, De Angelis, Flavia, de Azevedo, Sergio Jobim, De Marchi, Pedro Rafael Martins, de The Bustamante Valles, Flor, Doganov, Boyan, Dreosti, Lydia, Duarte, Ricardo, Erman, Mustafa, Fein, Luis, Feng, Jifeng, Fenton, David, Fernandes, Gustavo, Ferreira, Carlos, Fujisaka, Yasuhito, Galvez, Christina, Gil, Nuno, Hall, Jacqueline, Hart, Gregory, He, Yong, Ho, Chung Man James, Horiike, Atsushi, Hu, Yi, Ichiki, Masao, Imamura, Fumio, Jassem, Jacek, Jordaan, Christa, Kaen, Diego, Katakami, Nobuyuki, Kato, Terufumi, Kawaguchi, Tomoya, Kim, Joo Hang, Kowalyszyn, Ruben, Ksienski, Doran, Kubota, Kaoru, Kuusk, Gerli, Laczo, Ibolya, Landers, Gregory, Lazarev, Sergey, Li, Wei, Liu, Zhe, Lopes, Valeria, Lu, Shun, Mas, Luis, Milanova, Zhasmina, Nakahara, Yasuharu, Ohman, Ronny, Ong, Choo Khoon, Ostoros, Gyula, Qin, Shukui, Ramlau, Rodryg, Richardet, Eduardo, Roubec, Jaromir, Rusyn, Andrii, Seki, Nobuhiko, Shimada, Andrea Kazumi, Shparyk, Yaroslav, Sinielnikov, Ivan, Soares, Joao Paulo Holanda, Stara, Zinaida, Tanaka, Hiroshi, Tang, Qiyou, Taranov, Pavel, Tejada, Hermes, Torii, Yoshitaro, Trukhyn, Dmytro, Turdean, Maria, Vera, Luis, Vynnychenko, Ihor, Wang, Jie, Wang, Kai, Yumuk, Fulden, Zambrano, Angela, Zemaitis, Marius, Zhao, Jun, Zhou, Jianying

Volltext

A Postauthorization Survey to Document the Therapeutic Management of Oxaliplatin as a First-Line Chemotherapy Regimen in South Africa in Patients with Metastatic Colorectal Cancer von Dreosti, Lydia M., McMaster, Alicia, Mothilal, Rashem

Volltext

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial von Özgüroğlu, Mustafa, Mandalà, Mario, Ryu, Min-Hee, Olesiński, Tomasz, Mansoor, Wasat, Shacham-Shmueli, Einat, Chen, Xinqun, Kang, S Peter, Fuchs, Charles S, Lerzo, Guillermo, Lynam, James, Wong, Mark, Vasey, Paul, Van Laethem, Jean-Luc, Van Cutsem, Eric, Berry, Scott, Vincent, Mark, Muller, Bettina, Rey, Felipe, Zambrano, Angela, Guerra, Joaquin, Krogh, Merete, Yilmaz, Mette, Elme, Anneli, Auvinen, Paivi, Alanko, Tuomo, Moehler, Markus, Kunzmann, Volker, Hoehler, Thomas, Haag, Georg, Castro, Hugo, Aguilar Vasquez, Mynor, Cuffe, Sinead, Geva, Ravit, Hubert, Ayala, Beny, Alex, Giuseppe, Aprile, Passalacqua, Rodolfo, Montesarchio, Vincenzo, Chin, Keisho, Nishina, Tomohiro, Komatsu, Yoshito, Hironaka, Shuichi, Satoh, Taroh, Tamura, Takao, Sugimoto, Naotaoshi, Cho, Haruhiko, Omuro, Yashushi, Kato, Ken, Goto, Masahiro, Hyodo, Ichinosuke, Yoshida, Kazuhiro, Baba, Hideo, Esaki, Taito, Furuse, Junji, Wan Mohammed, Wan Zamaniah, Dominguez Andrade, Adriana, Glenjen, Nils, Kubiatowski, Tomasz, Jacek, Jassem, Wojtukiewicz, Marek, Lazarev, Sergey, Lancukhay, Yuri, Moiseyenko, Vladimir, Kostorov, Vladimir, Shirinkin, Vadim, Sakaeva, Dina, Fadeeva, Natalia, Yong, Wei Peng, Robertson, Barbara, Rapaport, Bernardo, Cohen, Graham, Dreosti, Lydia, Szpak, Waldemar, Roh, Sang-Young, Kim, Yeul Hong, Chung, Hyun Cheol, Ryu, Min-Hee, Longo Munoz, Federico, Cervantes Aguilar, Andres, Garcia Alfonso, Pilar, Feliu Batle, Jaime, Yeh, Kun-Huei, Chen, Jen-Shi, Chao, Yee, Kara, Oguz, Hochhauser, Daniel, Chau, Ian, Shaib, Walid, Philip, Philip, Sharma, Vivek, Sun, Weijing, George, Ben, Bullock, Andrea, Myrick, Samuel, Faruol, Josephine, Siegel, Richard, Becerra, Carlos, Richards, Donald A., Riche, Stephen L.

Volltext

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial von Baselga, José, Dr, Bradbury, Ian, PhD, Eidtmann, Holger, MD, Di Cosimo, Serena, MD, de Azambuja, Evandro, MD, Aura, Claudia, MD, Gómez, Henry, MD, Dinh, Phuong, MD, Fauria, Karine, PhD, Van Dooren, Veerle, MSc, Aktan, Gursel, MD, Goldhirsch, Aron, MD, Chang, Tsai-Wang, MD, Horváth, Zsolt, MD, Coccia-Portugal, Maria, MD, Domont, Julien, MD, Tseng, Ling-Min, MD, Kunz, Georg, MD, Sohn, Joo Hyuk, MD, Semiglazov, Vladimir, MD, Lerzo, Guillermo, MD, Palacova, Marketa, MD, Probachai, Volodymyr, MD, Pusztai, Lajos, DPhil, Untch, Michael, PhD, Gelber, Richard D, PhD, Piccart-Gebhart, Martine, PhD

Volltext

Insights into the epidemiology of renal cell carcinoma in North Africa and the Middle East von Marwan Ghosn, Mohammed Jaloudi, Blaha Larbaoui, Salim Adib, Lydia Dreosti, Jamal Zekri

Volltext

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled p... von Paz-Ares, Luis, Dr, Mezger, Jörg, Prof, Ciuleanu, Tudor E, Prof, Fischer, Jürgen R, MD, von Pawel, Joachim, MD, Provencio, Mariano, Prof, Kazarnowicz, Andrzej, MD, Losonczy, György, Prof, de Castro, Gilberto, MD, Szczesna, Aleksandra, MD, Crino, Lucio, MD, Reck, Martin, MD, Ramlau, Rodryg, Prof, Ulsperger, Ernst, MD, Schumann, Christian, MD, Miziara, Jose Elias A, MD, Lessa, Álvaro E, MD, Dediu, Mircea, MD, Bálint, Beatrix, PhD, Depenbrock, Henrik, MD, Soldatenkova, Victoria, MSc, Kurek, Raffael, MD, Hirsch, Fred R, Prof, Thatcher, Nick, FRCP, Socinski, Mark A, Prof

Volltext

Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve... von Johnston, Stephen, Basik, Mark, Hegg, Roberto, Lausoontornsiri, Wirote, Grzeda, Lukasz, Clemons, Mark, Dreosti, Lydia, Mann, Helen, Stuart, Mary, Cristofanilli, Massimo

Volltext

Preliminary results from CECILIA, an open-label global safety study of bevacizumab (BEV), carboplatin (C) and paclitaxel (P) therapy for metastatic, recurrent or persistent cervica... von Redondo, Andres, Colombo, Nicoletta, Dreosti, Lydia Mary, McCormack, Mary, Rodrigues, Angelica Nogueira, Donica, Margarita, Morales, Leilani, González-Martín, Antonio

Volltext

A Post-Authorization Survey Documenting the Therapeutic Management of Oxaliplatin as First-Line Chemotherapy in South African Patients with Metastatic Colorectal Cancer von Dreosti, Lydia, Mothilal, Rashem, Mcmaster, Alicia

Volltext

Survival of patients with Kaposi sarcoma in the South African antiretroviral treatment era: a retrospective cohort study von Sengayi, Mazvita, Kielkowski, Danuta, Egger, Matthias, Dreosti, Lydia, Bohlius, Julia

Volltext

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's p... von Gligorov, J, Ataseven, B, Verrill, M, De Laurentiis, M, Jung, K.H, Azim, H.A, Al-Sakaff, N, Lauer, S, Shing, M, Pivot, X

Volltext

Insights into the epidemiology of renal cell carcinoma in North Africa and the Middle East von Marwan Ghosn, Mohammed Jaloudi, Blaha Larbaoui, Salim Adib, Lydia Dreosti, Jamal Zekri

Volltext

Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International, Multi-center, Ret... von Brittain, David, Akhtar, Saad, Rodrigues, Sylvia, Patel, Moosa, Moodley, Dhaya, Singh, Jaimendra Prithipal, Dreosti, Lydia M, Mohamed, Zainab, Al-mansour, Mubarak, Alzahrani, Mohsen, Rauf, M Shahzad, Maghfoor, Irfan, Kalayoğlu Beşişik, Sevgi, Boğa, Can, Saydam, Guray, Huang, Zhongwen, Pinchevsky, Jan, Ferhanoğlu, Burhan

Volltext